We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
SpringHill Bioventures Sdn Bhd (SHB), in which Khazanah Nasional Bhd is an investor,
has forged an alliance with India's listed Glenmark Laboratories Ltd to form
a US$270 million (US$1 = RM3.80) fully-integrated pharmaceutical company.
Encysive Pharmaceuticals announced the signing of a new licensing and related
agreements with Revotar Biopharmaceuticals AG, the Company's majority-owned
German subsidiary, regarding bimosiamose and certain follow-on compounds.
Brazilian drugmakers' federation Febrafarma expects the local industry to invest
some US$313.8mn this year, two-thirds of which is likely to be earmarked for
upgrades to production technology.
According to reports in the UK media, purchasers for state-run
healthcare provider the National Health Service (NHS) recently unwittingly acquired
and distributed HIV/AIDS therapies destined for Sub-Saharan African countries.